Clinical Trial Update: A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating nivolumab with hydroxychloroquine or nivolumab with ipilimumab plus hydroxychloroquine in advanced melanoma; currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Opdivo (nivolumab) (nivolumab)
• Plaquenil (hydroxychloroquine) (hydroxychloroquine)
• Yervoy (Ipilimumab) (Ipilimumab)

Snippet

Sponsor: Ravi Amaravadi, MD | Conditions: Melanoma | Phase 1, Phase 2 | Status: RECRUITING